{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:17:09Z","timestamp":1773339429760,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T00:00:00Z","timestamp":1491350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ebiom.2017.04.010","type":"journal-article","created":{"date-parts":[[2017,4,7]],"date-time":"2017-04-07T03:16:57Z","timestamp":1491535017000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection"],"prefix":"10.1016","volume":"19","author":[{"given":"Steven","family":"Rockman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Lowther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarina","family":"Camuglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Vandenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lou","family":"Fabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Miescher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Pearse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darryl","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2017.04.010_bb0005","author":"WHO"},{"issue":"3","key":"10.1016\/j.ebiom.2017.04.010_bb0010","doi-asserted-by":"crossref","first-page":"e9694","DOI":"10.1371\/journal.pone.0009694","article-title":"Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease","volume":"5","author":"Morgan","year":"2010","journal-title":"PLoS One"},{"issue":"4 Suppl","key":"10.1016\/j.ebiom.2017.04.010_bb0015","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/CCM.0b013e3181c85d5f","article-title":"H1N1 novel influenza A in pregnant and immunocompromised patients","volume":"38","author":"Lapinsky","year":"2010","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.ebiom.2017.04.010_bb0020","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0031-1283281","article-title":"Influenza drug resistance","volume":"32","author":"Pizzorno","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"issue":"Suppl. 1","key":"10.1016\/j.ebiom.2017.04.010_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2009.04022.x","article-title":"Intravenous immunoglobulins\u2014understanding properties and mechanisms","volume":"158","author":"Durandy","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.ebiom.2017.04.010_bb0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/CDLI.8.5.859-863.2001","article-title":"Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases","volume":"8","author":"Hemming","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"4 Suppl","key":"10.1016\/j.ebiom.2017.04.010_bb0035","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/CCM.0b013e3181d44c1e","article-title":"Hark back: passive immunotherapy for influenza and other serious infections","volume":"38","author":"Luke","year":"2010","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.ebiom.2017.04.010_bb0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.ebiom.2017.04.010_bb0045","first-page":"489","article-title":"Successful treatment of avian influenza with convalescent plasma","volume":"12","author":"Kong","year":"2006","journal-title":"Hong Kong Med. J."},{"issue":"14","key":"10.1016\/j.ebiom.2017.04.010_bb0050","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMc070359","article-title":"Treatment with convalescent plasma for influenza A (H5N1) infection","volume":"357","author":"Zhou","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ebiom.2017.04.010_bb0055","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.ebiom.2017.04.010_bb0060","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI41902","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"Corti","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.ebiom.2017.04.010_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3201\/eid1401.061283","article-title":"Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza","volume":"14","author":"Gioia","year":"2008","journal-title":"Emerg. Infect. Dis."},{"issue":"11","key":"10.1016\/j.ebiom.2017.04.010_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007918","article-title":"Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin","volume":"4","author":"Garcia","year":"2009","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ebiom.2017.04.010_bb0075","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/cid\/cir121","article-title":"Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies","volume":"52","author":"Sui","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"24","key":"10.1016\/j.ebiom.2017.04.010_bb0080","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1016\/j.vaccine.2012.03.043","article-title":"Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines","volume":"30","author":"Rockman","year":"2012","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.ebiom.2017.04.010_bb0085","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1128\/JVI.00241-09","article-title":"Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization","volume":"83","author":"Middleton","year":"2009","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ebiom.2017.04.010_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/clinids\/10.1.56","article-title":"Lessons for human influenza from pathogenicity studies with ferrets","volume":"10","author":"Smith","year":"1988","journal-title":"Rev. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ebiom.2017.04.010_bb0095","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2353\/ajpath.2007.070248","article-title":"Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals","volume":"171","author":"van Riel","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.ebiom.2017.04.010_bb0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0003-2697(79)90362-2","article-title":"Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-d-N-acetylneuraminate) substrate","volume":"94","author":"Potier","year":"1979","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.ebiom.2017.04.010_bb0105","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/JCM.41.2.742-750.2003","article-title":"Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network","volume":"41","author":"Wetherall","year":"2003","journal-title":"J. Clin. Microbiol."},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2017.04.010_bb0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vetimm.2008.12.009","article-title":"Quantitative analysis of inflammatory cytokines expression in peripheral blood mononuclear cells of the ferret (Mustela putorius furo) using real-time PCR","volume":"130","author":"Nakata","year":"2009","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"2","key":"10.1016\/j.ebiom.2017.04.010_bb0115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.virol.2007.01.002","article-title":"Early cytokine mRNA expression profiles predict morbillivirus disease outcome in ferrets","volume":"362","author":"Svitek","year":"2007","journal-title":"Virology"},{"issue":"2\u20134","key":"10.1016\/j.ebiom.2017.04.010_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.vetimm.2009.08.012","article-title":"Structure and sequence variation of the canine perforin gene","volume":"133","author":"Neta","year":"2010","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"3","key":"10.1016\/j.ebiom.2017.04.010_bb0125","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2249.1998.00538.x","article-title":"Effective prophylaxis of influenza A virus pneumonia in mice by topical passive immunotherapy with polyvalent human immunoglobulins or F(ab')2 fragments","volume":"111","author":"Ramisse","year":"1998","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.ebiom.2017.04.010_bb0130","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/JVI.02434-12","article-title":"Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine","volume":"87","author":"Rockman","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2017.04.010_bb0135","doi-asserted-by":"crossref","first-page":"13577","DOI":"10.1038\/ncomms13577","article-title":"Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses","volume":"7","author":"Wang","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ebiom.2017.04.010_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.ebiom.2017.04.010_bb0145","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1128\/JVI.01336-12","article-title":"Hemagglutinin stalk-reactive antibodies are boosted following sequential infection with seasonal and pandemic H1N1 influenza virus in mice","volume":"86","author":"Krammer","year":"2012","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ebiom.2017.04.010_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virol.2012.06.003","article-title":"Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice","volume":"432","author":"Easterbrook","year":"2012","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.ebiom.2017.04.010_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.ebiom.2017.04.010_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2249.2009.04081.x","article-title":"The other side of immunoglobulin G: suppressor of inflammation","volume":"160","author":"Aschermann","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.ebiom.2017.04.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002071","article-title":"Passively administered pooled human immunoglobulins exert IL-10 dependent anti-inflammatory effects that protect against fatal HSV encephalitis","volume":"7","author":"Ramakrishna","year":"2011","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.ebiom.2017.04.010_bb0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nm.1929","article-title":"Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10","volume":"15","author":"Sun","year":"2009","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ebiom.2017.04.010_bb0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/JVI.01732-09","article-title":"Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment","volume":"84","author":"Steel","year":"2010","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.ebiom.2017.04.010_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026335","article-title":"A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus","volume":"6","author":"Marcelin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2017.04.010_bb0185","doi-asserted-by":"crossref","first-page":"b3928","DOI":"10.1136\/bmj.b3928","article-title":"Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A\/H1N1 2009: case-control study in Mexico City","volume":"339","author":"Garcia-Garcia","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ebiom.2017.04.010_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010722","article-title":"Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel","volume":"5","author":"Johns","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ebiom.2017.04.010_bb0195","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ebiom.2017.04.010_bb0200","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies","volume":"190","author":"Jegaskanda","year":"2013","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.ebiom.2017.04.010_bb0205","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/infdis\/jit294","article-title":"Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1","volume":"208","author":"Jegaskanda","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.ebiom.2017.04.010_bb0210","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J. Virol."},{"issue":"7456","key":"10.1016\/j.ebiom.2017.04.010_bb0215","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ebiom.2017.04.010_bb0220","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.02481-15","article-title":"Hemagglutinin stalk immunity reduces influenza virus replication and transmission in ferrets","volume":"90","author":"Nachbagauer","year":"2015","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.ebiom.2017.04.010_bb0225","doi-asserted-by":"crossref","first-page":"15606","DOI":"10.18632\/oncotarget.7244","article-title":"Sialylated immunoglobulin G can neutralize influenza virus infection through receptor mimicry","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"issue":"Suppl. 1","key":"10.1016\/j.ebiom.2017.04.010_bb0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/cei.12527","article-title":"Role of sialylation in the anti-inflammatory activity of intravenous immunoglobulin - F(ab')(2) versus Fc sialylation","volume":"178","author":"Schwab","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.ebiom.2017.04.010_bb0235","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/infdis\/jiu334","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses","volume":"210","author":"Jegaskanda","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ebiom.2017.04.010_bb0240","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmii.2010.07.001","article-title":"A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G","volume":"44","author":"Chong","year":"2011","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"8","key":"10.1016\/j.ebiom.2017.04.010_bb0245","first-page":"610","article-title":"Clinical analysis of children with lymphoma complicated with severe pneumonia due to novel influenza A (H1N1) virus infection","volume":"48","author":"Zhang","year":"2010","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"4","key":"10.1016\/j.ebiom.2017.04.010_bb0250","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1442-200X.2010.03271.x","article-title":"Clinical characteristics of children with 2009 pandemic H1N1 influenza virus infections","volume":"53","author":"Dubnov-Raz","year":"2011","journal-title":"Pediatr. Int."},{"issue":"4","key":"10.1016\/j.ebiom.2017.04.010_bb0255","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/infdis\/jiv453","article-title":"INSIGHT FLU005: an anti-influenza virus hyperimmune intravenous immunoglobulin pilot study","volume":"213","author":"Group IFIPS","year":"2016","journal-title":"J. Infect. Dis."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396417301536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396417301536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T03:42:15Z","timestamp":1601869335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396417301536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":51,"alternative-id":["S2352396417301536"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2017.04.010","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2017.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}